Cita APA

Soares, P., Gadd, M. S., Frost, J., Galdeano, C., Ellis, L., Epemolu, O., . . . Ciulli, A. (2017). Group-Based Optimization of Potent and Cell-Active Inhibitors of the von Hippel–Lindau (VHL) E3 Ubiquitin Ligase: Structure–Activity Relationships Leading to the Chemical Probe (2S,4R)-1-((S)-2-(1-Cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (VH298). J Med Chem.

Citación estilo Chicago

Soares, Pedro, Morgan S. Gadd, Julianty Frost, Carles Galdeano, Lucy Ellis, Ola Epemolu, Sonia Rocha, Kevin D. Read, y Alessio Ciulli. "Group-Based Optimization of Potent and Cell-Active Inhibitors of the Von Hippel–Lindau (VHL) E3 Ubiquitin Ligase: Structure–Activity Relationships Leading to the Chemical Probe (2S,4R)-1-((S)-2-(1-Cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (VH298)." J Med Chem 2017.

Cita MLA

Soares, Pedro, et al. "Group-Based Optimization of Potent and Cell-Active Inhibitors of the Von Hippel–Lindau (VHL) E3 Ubiquitin Ligase: Structure–Activity Relationships Leading to the Chemical Probe (2S,4R)-1-((S)-2-(1-Cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (VH298)." J Med Chem 2017.